{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:33:49Z","timestamp":1790627629027,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003462.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T00:00:00Z","timestamp":1403827200000}}],"reference-count":88,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003462.pub3","type":"journal-article","created":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T16:49:06Z","timestamp":1403887746000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Heparin versus placebo for non-ST elevation acute coronary syndromes"],"prefix":"10.1002","volume":"2021","author":[{"given":"Carlos A","family":"Andrade-Castellanos","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine; Hospital Civil de Guadalajara \"Dr. Juan I. Menchaca\"; Guadalajara Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Enrique","family":"Colunga-Lozano","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact; McMaster University; Hamilton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Netzahualpilli","family":"Delgado-Figueroa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Hospital Civil de Guadalajara Dr. Juan I. Menchaca; Guadalajara Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk","family":"Magee","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine; Dalhousie University; Halifax Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,6,27]]},"reference":[{"issue":"19","key":"10.1002\/14651858.CD003462.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0002-9149(90)91155-Y","article-title":"Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group)","volume":"66","author":"Cohen","year":"1990","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD003462.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.89.1.81","article-title":"Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users","volume":"89","author":"Cohen","year":"1994","journal-title":"Circulation"},{"issue":"9","key":"10.1002\/14651858.CD003462.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.101.9.955","article-title":"Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty","volume":"101","author":"Doucet","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"25E","DOI":"10.1016\/S0002-9149(97)00486-4","article-title":"Low-molecular-weight heparin (Fragmin) during instability in coronary artery disease (FRISC)","volume":"80","author":"Swahn","year":"1997","journal-title":"American College of Cardiology"},{"issue":"9001","key":"10.1002\/14651858.CD003462.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(96)91270-2","article-title":"Low-molecular-weight heparin during instability in coronary artery disease","volume":"347","author":"Wallentin","year":"1996","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD003462.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0735-1097(95)80001-W","article-title":"Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia","volume":"26","author":"Gurfinkel","year":"1995","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD003462.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0735-1097(94)90539-8","article-title":"Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina","volume":"24","author":"Holdright","year":"1994","journal-title":"Journal of the American College of Cardiology"},{"issue":"8719","key":"10.1002\/14651858.CD003462.pub3-BIB0008|cit8","first-page":"830","article-title":"Risk of myocardial infarction and death during treatment with low-dose aspirin and intravenous heparin in men with unstable coronary artery disease","volume":"336","author":"Wallentin","year":"1990","journal-title":"Lancet"},{"issue":"17","key":"10.1002\/14651858.CD003462.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","article-title":"Aspirin, heparin, or both to treat acute unstable angina","volume":"319","author":"Th\u00e9roux","year":"1988","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003462.pub3-BIB0010|cit10","first-page":"4","article-title":"Unstable angina pectoris: aspirin and heparin in a double-blind placebo-controlled study, their effects on the outcojjme of disease during hospitalization","volume":"33","author":"Averkov","year":"1993","journal-title":"Kardiologiya"},{"issue":"2","key":"10.1002\/14651858.CD003462.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0735-1097(95)90035-7","article-title":"Heparin and aspirin in unstable angina: insufficient sample size may lead to erroneous conclusions","volume":"25","author":"Bodo","year":"1995","journal-title":"Journal of the American College of Cardiology"},{"issue":"15","key":"10.1002\/14651858.CD003462.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0025-7753(00)71631-9","article-title":"Low molecular weigh heparin in the treatment of acute coronary syndromes without ST elevation: Unstable angina and non Q wave myocardial infarction","volume":"115","author":"Borja","year":"2000","journal-title":"Medicina Clinica"},{"issue":"8","key":"10.1002\/14651858.CD003462.pub3-BIB0013|cit13","first-page":"1147","article-title":"Dalteparin in the acute phase of unstable angina and non-Q-wave infarction","volume":"53","author":"Borja","year":"2000","journal-title":"Revista Espanola de Cardiologia"},{"issue":"20","key":"10.1002\/14651858.CD003462.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1001\/archinte.160.20.3169-a","article-title":"Dalteparin for unstable angina and non-Q-wave myocardial infarction","volume":"160","author":"Borja","year":"2000","journal-title":"Archives of Internal Medicine"},{"issue":"90","key":"10.1002\/14651858.CD003462.pub3-BIB0015|cit15","first-page":"1345","article-title":"Initial heparin therapy in acute myocardial infarction","volume":"13","author":"Brown","year":"1964","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0016|cit16","first-page":"146","article-title":"Comparative study of heparin and antiplatelets in treatment of preinfarction angina","volume":"34","author":"Charvat","year":"1989","journal-title":"Cardiologia"},{"issue":"5","key":"10.1002\/14651858.CD003462.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/0735-1097(93)90540-H","article-title":"Prospective comparison of unstable angina versus non-Q-wave myocardial infarction during antithrombotic therapy","volume":"22","author":"Cohen","year":"1993","journal-title":"Journal of the American College of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD003462.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0735-1097(03)01040-4","article-title":"The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial","volume":"42","author":"Cohen","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1001\/jama.276.23.1873c","article-title":"Benefit of heparin plus aspirin vs aspirin alone in unstable angina","volume":"276","author":"Collins","year":"1996","journal-title":"JAMA"},{"issue":"9710","key":"10.1002\/14651858.CD003462.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(09)62127-9","article-title":"Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial","volume":"375","author":"Kedhi","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD003462.pub3-BIB0021|cit21","first-page":"475","article-title":"The role of low molecular weight heparin in unstable angina, acute myocardial infarction and post-elective percutaneous transluminal coronary angioplasty","volume":"65","author":"Correia","year":"1995","journal-title":"Arquivos Brasileiros de Cardiologia"},{"issue":"4","key":"10.1002\/14651858.CD003462.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.293.4.427","article-title":"Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes inpatients with acute myocardial infarction presenting with ST-segment elevation","volume":"293","author":"Yusuf","year":"2005","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0023|cit23","first-page":"533","article-title":"Low molecular weight heparin for treatment of acute myocardial infarction (FAMI): Fragmin (dalteparin sodium) in acute myocardial infarction","volume":"52","author":"Kakkar","year":"2000","journal-title":"Indian Heart Journal"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00003495-199958060-00002","article-title":"Platelet Glycoprotein IIb\/IIa receptor antagonists current concepts and future directions","volume":"58","author":"Ferguson","year":"1999","journal-title":"Drugs"},{"issue":"9180","key":"10.1002\/14651858.CD003462.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(99)07350-X","article-title":"Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study","volume":"354","author":"Ragmin","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD003462.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/01.CIR.77.5.1022","article-title":"Improvement of treadmill capacity and collateral circulation as a result of exercise with heparin pretreatment in patients with effort angina","volume":"77","author":"Fujita","year":"1988","journal-title":"Circulation"},{"issue":"8707","key":"10.1002\/14651858.CD003462.pub3-BIB0027|cit27","first-page":"65","article-title":"GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction","volume":"336","author":"Feruglio","year":"1990","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003462.pub3-BIB0028|cit28","first-page":"229","article-title":"Heparin in myocardial infarction and unstable angina","volume":"38","author":"Gorski","year":"1993","journal-title":"Kardiologia Polska"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0140-6736(99)00264-0","article-title":"Contemporary approach to management of unstable angina","volume":"354","author":"Goy","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD003462.pub3-BIB0030|cit30","first-page":"35","article-title":"Heparin therapy in coronary heart disease","volume":"117","author":"Gulba","year":"1992","journal-title":"Deutsche Medizinische Wochenschrift"},{"issue":"1","key":"10.1002\/14651858.CD003462.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0272989X9801800110","article-title":"Meta-analysis of multitreatment studies","volume":"18","author":"Hasselblad","year":"1998","journal-title":"Medical Decision Making"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0049-3848(89)90308-3","article-title":"Heparin induced increase of T-PA antigen plasma levels in patients with unstable angina: no evidence for clinical benefit of heparinization during the initial phase of treatment","volume":"55","author":"Huber","year":"1989","journal-title":"Thrombosis Research"},{"issue":"5","key":"10.1002\/14651858.CD003462.pub3-BIB0033|cit33","first-page":"463","article-title":"Acute myocardial infarction treated with anticoagulants","volume":"54","author":"Hurtado","year":"1984","journal-title":"Archivos del Instituto de Cardiologia de Mexico"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0002-8703(93)90688-6","article-title":"Therapeutic approach to unstable angina: nitroglycerin, heparin, and combined therapy","volume":"126","author":"Jaffrani","year":"1993","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0735-1097(00)00648-3","article-title":"Low molecular weight heparin in acute coronary syndrome: evidence for superior or equivalent efficacy compared with unfractionated heparin","volume":"35","author":"Kaul","year":"2000","journal-title":"Journal of the American College of Cardiology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD003462.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"I3","DOI":"10.1002\/clc.4960241303","article-title":"Improving outcomes in acute coronary syndromes - the FRISC II trial","volume":"24","author":"Kontny","year":"2001","journal-title":"Clinical Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD003462.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1067\/mhj.2002.121808","article-title":"Enoxaparin in acute coronary syndromes: Evidence for superiority over placebo or untreated control","volume":"143","author":"Massel","year":"2002","journal-title":"American Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD003462.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/clc.4960220310","article-title":"Efficacy and tolerability of a very low molecular weight heparin compared with standard heparin in patients with unstable angina: a pilot study","volume":"22","author":"Mattioli","year":"1999","journal-title":"Clinical Cardiology"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0039|cit39","first-page":"433","article-title":"Koronarer bypass: erfolg hangt oft von psyche ab","volume":"8","year":"1989","journal-title":"Arch Medici Nr"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/circ.90.2.8044926","article-title":"Aspirin versus heparin in the acute phase of unstable angina","volume":"90","author":"Moise","year":"1994","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0140-6736(95)91294-0","article-title":"Heparin in unstable angina","volume":"346","author":"Montgomery","year":"1995","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003462.pub3-BIB0042|cit42","first-page":"171","article-title":"Study on the efficacy of heparin and aspirin in unstable angina and acute heart infarction","volume":"10","author":"Nardelli","year":"1991","journal-title":"Clinica e Terapia Cardiovascolare"},{"issue":"13","key":"10.1002\/14651858.CD003462.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.295.13.joc60038","article-title":"Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial","volume":"295","author":"Yusuf","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0044|cit44","first-page":"222","article-title":"Low molecular weight heparin in unstable angina pectoris","volume":"69","author":"Ocampo","year":"1999","journal-title":"Archivos del Instituto de Cardiologia de Mexico"},{"issue":"3","key":"10.1002\/14651858.CD003462.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/eurheartj\/ehm578","article-title":"Effects of fondaparinux in patients withST-segment elevation acute myocardial infarction not receiving reperfusion treatment","volume":"29","author":"Oldgren","year":"2008","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jama.1996.03540100055028","article-title":"Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina","volume":"276","author":"Oler","year":"1996","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD003462.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0002-9149(00)01426-0","article-title":"Prognostic Importance of ConcomitantHeparin With Eptifibatide in AcuteCoronary Syndromes","volume":"87","author":"Peterson","year":"2001","journal-title":"American Journal of Cardiology"},{"issue":"23","key":"10.1002\/14651858.CD003462.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1161\/hc4801.100358","article-title":"Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb\/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb\/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial","volume":"104","author":"Lauer","year":"2001","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"874","DOI":"10.7326\/0003-4819-119-9-199311010-00002","article-title":"The weight-based heparin dosing nomogram compared with a \"standard care\" nomogram","volume":"119","author":"Raschke","year":"1993","journal-title":"Annals of Internal Medicine"},{"issue":"16","key":"10.1002\/14651858.CD003462.pub3-BIB0050|cit50","first-page":"638","article-title":"Low-molecular-weight heparins in unstable angina and non-Q-wave myocardial infarction","volume":"116","author":"Rubio-Terres","year":"2001","journal-title":"Medicina Clinica"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0051|cit51","first-page":"141","article-title":"Unstable angina, myocardial infarction, heparin and death: medium dose heparin (not exceeding 20,000 units\/day) in the treatment of patients with acute coronary event - first year and long-term comparative mortality","volume":"94","author":"Sayen","year":"1982","journal-title":"Transactions of the American Clinical & Climatological Association"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0002-8703(88)90518-2","article-title":"Decrease in frequency of anginal episodes by control of thrombin generation with low-dose heparin: a controlled cross-over randomized study","volume":"115","author":"Serneri","year":"1988","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0140-6736(90)90407-V","article-title":"Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina","volume":"335","author":"Serneri","year":"1990","journal-title":"Lancet"},{"issue":"8959","key":"10.1002\/14651858.CD003462.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0140-6736(95)91990-2","article-title":"Randomised comparison of subcutaneous heparin, intravenous heparin, and aspirin in unstable angina. Studio Epoorine Sottocutanea nell'Angina Instobile (SESAIR) Refrattorie Group","volume":"345","author":"Serneri","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJM198904133201515","article-title":"Aspirin, heparin, or both to treat unstable angina","volume":"320","author":"Spodick","year":"1989","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003462.pub3-BIB0056|cit56","first-page":"95","article-title":"Use of heparin in coronary angioplasty: randomized trial in low risk patients for abrupt closure","volume":"60","author":"Tanajura","year":"1993","journal-title":"Arquivos Brasileiros de Cardiologia"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1026543107533","article-title":"The TETAMI Trial: the safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute myocardial infarction for patients not thrombolyzed: methods and design","volume":"10","author":"Cohen","year":"2000","journal-title":"Journal of Thrombosis & Thrombolysis"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD003462.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/01.CIR.88.5.2045","article-title":"Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina","volume":"88","author":"Th\u00e9roux","year":"1993","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0059|cit59","first-page":"88","article-title":"Management of unstable angina pectoris with maximal medical treatment (combination of intravenous nitrates, beta-blockers, calcium antagonists and heparin)","volume":"39","author":"Thieuleux","year":"1985","journal-title":"Bibliotheca Cardiologica"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(05)64172-4","article-title":"The CAPTURE trial","volume":"350","author":"Umans","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0140-6736(91)93423-7","article-title":"Low-dose aspirin and heparin in unstable coronary artery disease","volume":"337","author":"Violaris","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"61E","DOI":"10.1016\/S0002-9149(97)00493-1","article-title":"Long-term low-molecular-weight heparin (Fragmin) and\/or early revascularization during instability in coronary artery disease (the FRISC II study)","volume":"80","author":"Wallentin","year":"1997","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0002-8703(91)90456-R","article-title":"Failure of adjuvant heparin to reduce myocardial ischemia in the early treatment of patients with unstable angina","volume":"122","author":"Wallis","year":"1991","journal-title":"American Heart Journal"},{"issue":"Suppl IV","key":"10.1002\/14651858.CD003462.pub3-BIB0064|cit64","first-page":"IV","article-title":"Heparin in the treatment of unstable angina: a randomized prospective trial","volume":"76","author":"Zwerner","year":"1987","journal-title":"Circulation"},{"issue":"23","key":"10.1002\/14651858.CD003462.pub3-BIB0065|cit65","first-page":"e179-347","article-title":"2012 ACCF\/AHA focused update incorporated into the guideline for the management of patients with unstable angina\/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force onPractice Guidelines","volume":"61","author":"Anderson","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD003462.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0735-1097(95)00404-1","article-title":"One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction","volume":"26","author":"Anderson","year":"1995","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD003462.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2007.11.057","article-title":"Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events","volume":"101","author":"Bowry","year":"2008","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0068|cit68","first-page":"239","article-title":"One year mortality outcomes of all coronary and intensive care unit patients with acute myocardial infarction, unstable angina or chest pain in Hamilton, Ontario, a city of 375,000 people","volume":"319","author":"Cairns","year":"1989","journal-title":"Canadian Journal of Cardiology"},{"issue":"Suppl E","key":"10.1002\/14651858.CD003462.pub3-BIB0069|cit69","first-page":"11E","article-title":"Approaches to the treatment of unstable angina and non-Q wave myocardial infarction","volume":"14","author":"Cohen","year":"1998","journal-title":"Canadian Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD003462.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1987","journal-title":"Controlled Clinical Trials"},{"issue":"9219","key":"10.1002\/14651858.CD003462.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(00)02324-2","article-title":"Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis","volume":"355","author":"Eikelboom","year":"2000","journal-title":"Lancet"},{"issue":"23","key":"10.1002\/14651858.CD003462.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","article-title":"ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)","volume":"32","author":"Hamm","year":"2011","journal-title":"European Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD003462.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7326\/0003-4819-146-6-200703200-00008","article-title":"Role of clopidogrel in managing atherothrombotic cardiovascular disease","volume":"146","author":"Eshaghian","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003462.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","article-title":"Coronary plaque disruption","volume":"92","author":"Falk","year":"1995","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0076|cit76","volume-title":"Cochrane Handbook for Systematic Reviews of Intervention","author":"Higgins","year":"2011"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"489S","DOI":"10.1378\/chest.114.5_Supplement.489S","article-title":"Heparin and low molecular weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety","volume":"114","author":"Hirsh","year":"1998","journal-title":"Chest"},{"issue":"7","key":"10.1002\/14651858.CD003462.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","article-title":"Proctective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results for a Veterans Administration Cooperative Study","volume":"309","author":"Davis","year":"1983","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD003462.pub3-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002132","article-title":"Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes (Cochrane Review)","author":"Magee","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003462.pub3-BIB0081|cit81","first-page":"II24","article-title":"Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: predictors, prognostic significance, and paradigms for reducing risk","volume":"10","author":"Manoukian","year":"2007","journal-title":"Clinical Cardiology"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomized controlled trials","volume":"342","author":"Sterne","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD003462.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.CIR.89.4.1545","article-title":"Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia","volume":"89","author":"The TIMI IIIB Investigators","year":"1994","journal-title":"Circulation"},{"issue":"20","key":"10.1002\/14651858.CD003462.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/archinte.163.20.2518","article-title":"An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients","volume":"163","author":"Warkentin","year":"2003","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD003462.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","article-title":"Low molecular weight heparins","volume":"337","author":"Weitz","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD003462.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003462.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"e316242","DOI":"10.1371\/journal.pone.0031642","article-title":"Effects of combined aspirin and clopidogrel therapy on cardiovascular outcomes: a systematic review and meta-analysis","volume":"7","author":"Zhou","year":"2012","journal-title":"PloS One"},{"issue":"2","key":"10.1002\/14651858.CD003462.pub3-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003462.pub2","article-title":"Heparin versus placebo for acute coronary syndromes","author":"Magee","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003462.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T01:33:04Z","timestamp":1686187984000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003462.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,27]]},"references-count":88,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003462.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,27]]}}}